Last 40 quarters of trend data · Healthcare · Drug Manufacturers - General
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Grifols, S.A.'s quarterly P/E stands at 18.2x, down 10.0% year-over-year. EV/EBITDA has expanded 8.3% YoY to 10.1x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 11.16 | 18.23 | 16.70 | 13.11 | 13.29 | 20.24 | 18.60 | 29.17 | 78.88 | 55.48 | 35.07 | 26.03 | 21.69 |
| — | -10.0% | -10.2% | -55.1% | -83.1% | -63.5% | -47.0% | +12.1% | +263.7% | +143.9% | +151.1% | +152.0% | -77.2% | |
| P/S Ratio | 0.74 | 0.79 | 0.81 | 0.91 | 0.82 | 0.68 | 0.64 | 0.84 | 0.64 | 0.73 | 1.11 | 0.97 | 2.19 |
| — | +16.6% | +26.5% | +7.9% | +27.8% | -7.2% | -42.3% | -13.3% | -70.6% | -70.7% | -45.0% | -44.5% | +0.1% | |
| P/B Ratio | 0.57 | 0.69 | 0.84 | 0.90 | 0.82 | 0.58 | 0.59 | 0.75 | 0.56 | 0.58 | 1.04 | 0.72 | 1.71 |
| — | +19.1% | +42.4% | +18.6% | +45.1% | -0.2% | -43.7% | +4.3% | -66.9% | -64.4% | -44.3% | -53.5% | -0.7% | |
| P/FCF | 7.16 | 23.15 | 4.75 | 6.64 | 16.38 | 14.01 | 3.05 | 7.01 | 5.26 | — | 25.76 | 21.84 | 33.33 |
| — | +65.2% | +55.4% | -5.3% | +211.1% | — | -88.1% | -67.9% | -84.2% | — | +56.8% | +84.8% | +273.0% | |
| EV / EBITDA | 8.21 | 10.06 | 8.94 | 8.16 | 9.94 | 9.28 | 7.35 | 8.96 | 10.76 | 12.68 | 12.74 | 11.69 | 14.20 |
| — | +8.3% | +21.6% | -8.9% | -7.6% | -26.8% | -42.3% | -23.4% | -24.2% | -20.4% | +6.1% | +33.0% | -28.9% | |
| EV / EBIT | 11.20 | 14.26 | 13.29 | 11.20 | 10.91 | 12.05 | 15.64 | 12.02 | 13.06 | 16.22 | 23.34 | 16.74 | 19.70 |
| — | +18.3% | -15.0% | -6.8% | -16.4% | -25.7% | -33.0% | -28.2% | -33.7% | -29.4% | +46.0% | +44.3% | -43.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Grifols, S.A.'s operating margin was 14.6% in Q1 2026, up 0.8 pp QoQ and down 0.4 pp YoY. The trailing four-quarter average of 16.9% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 7.6% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.7% | 36.5% | 34.7% | 40.3% | 39.3% | 39.5% | 38.8% | 40.5% | 36.9% | 39.9% | 39.0% | 39.6% | 43.0% |
| — | -7.6% | -10.7% | -0.6% | +6.6% | -1.1% | -0.5% | +2.5% | -14.2% | -11.4% | -13.6% | -17.1% | +32.9% | |
| Operating Margin | 16.4% | 14.6% | 13.9% | 20.5% | 18.4% | 15.1% | 18.8% | 17.7% | 16.5% | 12.5% | 14.4% | 15.7% | 18.5% |
| — | -2.7% | -26.3% | +16.2% | +12.0% | +20.1% | +30.7% | +12.7% | -11.2% | -30.3% | -24.1% | -36.5% | +73.2% | |
| Net Margin | 5.3% | 4.3% | 5.0% | 6.8% | 6.2% | 3.3% | 3.5% | 2.9% | 0.8% | 1.3% | 3.2% | 3.7% | 10.1% |
| — | +28.4% | +42.0% | +136.1% | +658.2% | +153.8% | +10.3% | -22.7% | -91.9% | -88.0% | -68.8% | -81.1% | +339.7% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.8% | 1.0% | 1.3% | 1.7% | 1.5% | 0.7% | 0.8% | 0.6% | 0.2% | 0.3% | 0.7% | 0.8% | 1.9% |
| — | +35.9% | +54.4% | +163.8% | +714.8% | +158.0% | +19.3% | -17.4% | -90.7% | -85.3% | -69.6% | -82.6% | +333.0% | |
| ROA | 1.9% | 0.4% | 0.5% | 0.6% | 0.6% | 0.3% | 0.3% | 0.2% | 0.1% | 0.1% | 0.3% | 0.3% | 0.8% |
| — | +32.2% | +48.3% | +163.6% | +756.3% | +182.4% | +27.2% | -22.0% | -92.1% | -87.9% | -74.6% | -84.5% | +318.1% | |
| ROIC | 5.4% | 1.2% | 1.3% | 1.8% | 1.6% | 1.1% | 1.6% | 1.4% | 1.2% | 0.8% | 1.0% | 1.1% | 1.3% |
| — | +2.7% | -20.6% | +29.7% | +28.1% | +38.5% | +55.2% | +20.7% | -7.9% | -29.7% | -39.3% | -49.3% | +61.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Grifols, S.A.'s Debt/EBITDA ratio is 27.0x, up from 21.9x last quarter — elevated, raising questions about debt serviceability.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.15 | 1.23 | 1.15 | 1.28 | 1.16 | 1.21 | 1.17 | 1.23 | 1.39 | 1.40 | 1.47 | 1.29 | 1.10 |
| — | +1.7% | -1.9% | +4.1% | -16.3% | -13.7% | -20.1% | -4.5% | +26.3% | +37.0% | +42.3% | +30.1% | +9.7% | |
| Debt / EBITDA | 5.40 | 26.98 | 21.88 | 19.99 | 24.22 | 26.40 | 20.92 | 23.16 | 35.19 | 36.83 | 30.60 | 30.83 | 22.69 |
| — | +2.2% | +4.6% | -13.7% | -31.2% | -28.3% | -31.6% | -24.9% | +55.1% | +47.3% | +74.4% | +112.3% | -26.3% | |
| Current Ratio | 2.51 | 2.47 | 2.51 | 2.48 | 2.64 | 2.60 | 2.66 | 2.26 | 1.68 | 2.22 | 2.64 | 2.48 | 1.69 |
| — | -4.8% | -5.4% | +9.8% | +56.8% | +16.8% | +0.8% | -8.8% | -0.3% | +12.5% | +11.2% | -15.4% | -41.2% | |
| Quick Ratio | 0.88 | 0.85 | 0.88 | 0.93 | 0.95 | 0.97 | 1.01 | 0.79 | 0.80 | 1.02 | 1.14 | 0.75 | 0.58 |
| — | -13.2% | -12.4% | +17.1% | +19.2% | -4.8% | -11.7% | +5.0% | +37.9% | +68.7% | +30.8% | -43.3% | -51.0% | |
| Interest Coverage | 1.98 | 1.79 | 1.69 | 2.27 | 2.35 | 1.91 | 14.27 | 1.60 | 1.33 | 1.42 | 1.22 | 1.66 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 40 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GRFS stock.
Grifols, S.A.'s current P/E is 11.2x. The average P/E over the last 4 quarters is 15.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Grifols, S.A.'s current operating margin is 16.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Grifols, S.A.'s business trajectory between earnings reports.